In vitro Transdermal Transport of Domperidone by Compartmental Modeling Approach

  • Sekar Ayu Pawestri Department of Pharmaceutics, Faculty of Pharmacy, Universitas Gadjah Mada, Yogyakarta 55281, Indonesia
  • Akhmad Kharis Nugroho Departemen Farmasetika Fakultas Farmasi Universitas Gadjah Mada, Sekip Utara Yogyakarta
  • Endang Lukitaningsih Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Universitas Gadjah Mada, Yogyakarta 55281, Indonesia
Keywords: Transdermal, Domperidone, compartmental modeling, WinSAAM


Transdermal delivery can be alternatively chosen for domperidone to improve its low oral bioavailability. The development of drugs into transdermal formulation needs information about the transport mechanism of the drug. This study aimed to develop models of domperidone transdermal transport in vitro based on compartmental modeling for understanding the domperidone transport mechanism. Domperidone solution (0.5g/L in a citric buffer, pH 5) was filled into the donor compartment. A comparative study was also conducted to examine the effect of different pH on domperidone transdermal transport in pH 1 (4g/L in 0.1M HCl). The shed snake-skin and cellophane membrane were pretreated for 1h with a chemical enhancer (oleic acid in propylene glycol) and assembled between the donor and the vertical diffusion cell's receptor compartment. The receptor compartment was filled in with phosphate-buffered saline at a pH of 6.8. The permeation study was performed for 8h. Samples concentration was assayed by UV-spectrophotometry. The cumulative permeation profiles of domperidone were analyzed using WinSAAM. Three and four-compartmental models were proposed with one lag compartment. The evaluation of the appropriate number of compartments in the transport model was examined based on the visual goodness of fit (GOF) and the corrected Akaike's information criterion (AICc) values. The four-compartmental model with one lag compartment was the best model describing percutaneous domperidone transport either in pH donor of 5 or pH 1. The model indicates domperidone transport follows into two parallel routes, including a lag compartment.


Boyce, M.J., Baisley, K.J., Warrington, S.J., 2012. Pharmacokinetic interaction between domperidone and ketoconazole leads to QT prolongation in healthy volunteers: a randomized, placebo-controlled, double-blind, crossover study: QT study of domperidone and ketoconazole. British Journal of Clinical Pharmacology 73, 411–421.
Haque, T., Talukder, M.M.U., 2018. Chemical Enhancer: A Simplistic Way to Modulate Barrier Function of the Stratum Corneum. Advanced Pharmaceutical Bulletin 8, 169–179.
Hendriati, L., Nugroho, A.K., 2009. Pengaruh campuran asam oleat-propilen glikol dan iontoforesis terhadap transpor transdermal propranolol. Majalah Farmasi Indonesia 20, 217–223.
Heykants, J., Hendriks, R., Meuldermans, W., Michiels, M., Scheygrond, H., Reyntjens, H., 1981. On the pharmacokinetics of domperidone in animals and man IV. The pharmacokinetics of intravenous domperidone and its bioavailability in man following intramuscular, oral and rectal administration. European Journal of Drug Metabolism and Pharmacokinetics 6, 61–70.
Khanday, M.A., Rafiq, A., Nazir, K., 2017. Mathematical models for drug diffusion through the compartments of blood and tissue medium. Alexandria Journal of Medicine 53, 245–249.
Larrucea, E., 2001. Combined effect of oleic acid and propylene glycol on the percutaneous penetration of tenoxicam and its retention in the skin. European Journal of Pharmaceutics and Biopharmaceutics 52, 113–119.
Mortazavi, S.A., Aboofazeli, R., 2003. An Investigation into the Effect of Various Penetration Enhancers on Percutaneous Absorption of Piroxicam. Iranian Journal of Pharmaceutical Research 2, 135–140.
Motulsky, H.J., Christopoulus, A., 2003. Fitting models to biological data using linear and nonlinear regression. A practical guide to curve fitting. GraphPad Software, Inc. San Diego CA.
National Center for Biotechnology Information, 2019. Domperidone [WWW Document]. URL (accessed 8.30.19).
Nugroho, A.K., Binnarjo, A., Hakim, A.H., Ermawati, Y., 2014. Compartmental Modeling Approach of Losartan Transdermal Transport in Vitro. Indonesian Journal of Pharmacy 25, 31–38.
Nugroho, A.K., Della Pasqua, O., Danhof, M., Bouwstra, J.A., 2004. Compartmental Modeling of Transdermal Iontophoretic Transport: I. In Vitro Model Derivation and Application. Pharmaceutical Research 21, 1974–1984.
Nugroho, A.K., Della-Pasqua, O., Danhof, M., Bouwstra, J.A., 2005. Compartmental modeling of transdermal iontophoretic transport II: In vivo model derivation and application. Pharmaceutical Research 22, 335–346.
Pranitha, A., Lakshmi, P.K., 2018. Effect of pH on weakly acidic and basic model drugs and determination of their ex vivo transdermal permeation routes. Braz. J. Pharm. Sci. 54, 1–8.
Proksch, E., 2018. pH in nature, humans and skin. The Journal of Dermatology 45, 1044–1052.
Sarath, C., Vipin, K., Augusthy, A.R., Shahin, M., Sabna, N.S., 2014. Effectiveness of Sodium CMC as a Polymer for the Development of Transdermal Patches Containing Paracetamol IP in Paediatric Category. British Biomedical Bulletin 2, 174–186.
Singh, S., Singh, J., 1993. Transdermal drug delivery by passive diffusion and iontophoresis: A review. Med. Res. Rev. 13, 569–621.
Stefanovski, D., Moate, P.J., Boston, R.C., 2003. WinSAAM: A windows-based compartmental modeling system. Metabolism: Clinical and Experimental 52, 1153–1166.
How to Cite
Sekar Ayu Pawestri, Nugroho, A. K., & Endang Lukitaningsih. (2021). In vitro Transdermal Transport of Domperidone by Compartmental Modeling Approach. Indonesian Journal of Pharmacy, 32(1), 10-16.
Research Article